Caraco Feels The Sting Of FDA's Accelerated Response To GMP Violations
Executive Summary
FDA's fast action to seize drug products and ingredients at three Michigan facilities owned by Caraco Pharmaceutical Laboratories could reflect pressure from Reps. John Dingell and Bart Stupak to tighten controls on generic manufacturers